Global Oncolytic Virus Market Report 2016-2027 by Companies, Regions, Types and Application
SKU ID : HNY-19020892 | Publishing Date : 30-Aug-2021 | No. of pages : 153
Detailed TOC of Global Oncolytic Virus Market Report 2016-2027 by Companies, Regions, Types and Application
1 Market Overview of Oncolytic Virus1.1 Oncolytic Virus Market Overview
1.1.1 Oncolytic Virus Product Scope
1.1.2 Market Status and Outlook
1.2 Oncolytic Virus Market Size by Regions: 2016 VS 2022 VS 2027
1.3 Oncolytic Virus Historic Market Size by Regions (2016-2021)
1.4 Oncolytic Virus Forecasted Market Size by Regions (2022-2027)
1.5 Covid-19 Impact on Key Regions, Oncolytic Virus Market Size YoY Growth (2016-2027)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2 Covid-19 Impact Oncolytic Virus Sales Market by Type (2016-2027)
2.1 Global Oncolytic Virus Historic Market Size by Type (2016-2021)
2.2 Global Oncolytic Virus Forecasted Market Size by Type (2022-2027)
2.3 Imlygic
2.4 Oncorine
3 Covid-19 Impact Oncolytic Virus Consumption Market by Application(2016-2027)
3.1 Global Oncolytic Virus Historic Market Size by Application (2016-2021)
3.2 Global Oncolytic Virus Forecasted Market Size by Application (2022-2027)
3.3 Melanoma
4 Covid-19 Impact Market Competition by Manufacturers
4.1 Global Oncolytic Virus Production Capacity Market Share by Manufacturers (2016-2021)
4.2 Global Oncolytic Virus Revenue Market Share by Manufacturers (2016-2021)
4.3 Global Oncolytic Virus Average Price by Manufacturers (2016-2021)
4.4 Manufacturers Oncolytic Virus Production Sites, Area Served, Product Type
5 Company Profiles and Key Figures in Oncolytic Virus Business
5.1 Amgen
5.1.1 Amgen Company Profile
5.1.2 Amgen Oncolytic Virus Product Specification
5.1.3 Amgen Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
5.2 Oncolytics Biotech
5.2.1 Oncolytics Biotech Company Profile
5.2.2 Oncolytics Biotech Oncolytic Virus Product Specification
5.2.3 Oncolytics Biotech Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
5.3 Viralytics
5.3.1 Viralytics Company Profile
5.3.2 Viralytics Oncolytic Virus Product Specification
5.3.3 Viralytics Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
5.4 Transgene SA
5.4.1 Transgene SA Company Profile
5.4.2 Transgene SA Oncolytic Virus Product Specification
5.4.3 Transgene SA Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
5.5 Oncolys BioPharma
5.5.1 Oncolys BioPharma Company Profile
5.5.2 Oncolys BioPharma Oncolytic Virus Product Specification
5.5.3 Oncolys BioPharma Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
5.6 Targovax
5.6.1 Targovax Company Profile
5.6.2 Targovax Oncolytic Virus Product Specification
5.6.3 Targovax Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
5.7 PsiOxus Therapeutics
5.7.1 PsiOxus Therapeutics Company Profile
5.7.2 PsiOxus Therapeutics Oncolytic Virus Product Specification
5.7.3 PsiOxus Therapeutics Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
5.8 SillaJen Biotherapeutics
5.8.1 SillaJen Biotherapeutics Company Profile
5.8.2 SillaJen Biotherapeutics Oncolytic Virus Product Specification
5.8.3 SillaJen Biotherapeutics Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
5.9 Sorrento Therapeutics
5.9.1 Sorrento Therapeutics Company Profile
5.9.2 Sorrento Therapeutics Oncolytic Virus Product Specification
5.9.3 Sorrento Therapeutics Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
5.10 Lokon Pharma
5.10.1 Lokon Pharma Company Profile
5.10.2 Lokon Pharma Oncolytic Virus Product Specification
5.10.3 Lokon Pharma Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
5.11 Genelux Corporation
5.11.1 Genelux Corporation Company Profile
5.11.2 Genelux Corporation Oncolytic Virus Product Specification
5.11.3 Genelux Corporation Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
5.12 Vyriad
5.12.1 Vyriad Company Profile
5.12.2 Vyriad Oncolytic Virus Product Specification
5.12.3 Vyriad Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
5.13 TILT Biotherapeutics
5.13.1 TILT Biotherapeutics Company Profile
5.13.2 TILT Biotherapeutics Oncolytic Virus Product Specification
5.13.3 TILT Biotherapeutics Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
5.14 Cold Genesys
5.14.1 Cold Genesys Company Profile
5.14.2 Cold Genesys Oncolytic Virus Product Specification
5.14.3 Cold Genesys Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
6 North America
6.1 North America Oncolytic Virus Market Size (2016-2027)
6.2 Oncolytic Virus Key Players in North America (2016-2021)
6.3 North America Oncolytic Virus Market Size by Type (2016-2021)
6.4 North America Oncolytic Virus Market Size by Application (2016-2021)
7 East Asia
7.1 East Asia Oncolytic Virus Market Size (2016-2027)
7.2 Oncolytic Virus Key Players in East Asia (2016-2021)
7.3 East Asia Oncolytic Virus Market Size by Type (2016-2021)
7.4 East Asia Oncolytic Virus Market Size by Application (2016-2021)
8 Europe
9 South Asia
10 Southeast Asia
11 Middle East
12 Africa
13 Oceania
14 South America
15 Rest of the World
16 Oncolytic Virus Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
List of Figures, Tables and Charts Available in Global Oncolytic Virus Market Report 2016-2027 by Companies, Regions, Types and Application
Table 1. Global Oncolytic Virus Market Size by Regions (US$ Million): 2022-2027Table 2. Global Oncolytic Virus Market Size by Regions (2016-2021) (US$ Million)
Table 3. Global Oncolytic Virus Market Share by Regions (2016-2021)
Table 4. Global Oncolytic Virus Forecasted Market Size by Regions (2022-2027) (US$ Million)
Table 5. Global Oncolytic Virus Market Share by Regions (2022-2027)
Table 6. Overview of the World Economic Outlook Projections
Table 7. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 8. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 9. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 10. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 11. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 12. Covid-19 Impact: Global Major Government Policy
Table 13. Global Oncolytic Virus Market Size by Type (2016-2021) (US$ Million)
Table 14. Global Oncolytic Virus Revenue Market Share by Type (2016-2021)
Table 15. Global Oncolytic Virus Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 16. Global Oncolytic Virus Revenue Market Share by Type (2022-2027)
Table 17. Global Oncolytic Virus Market Size by Application (2016-2021) (US$ Million)
Table 18. Global Oncolytic Virus Revenue Market Share by Application (2016-2021)
Table 19. Global Oncolytic Virus Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 20. Global Oncolytic Virus Revenue Market Share by Application (2022-2027)
Table 21. Global Oncolytic Virus Production Capacity by Manufacturers
Table 22. Global Oncolytic Virus Production by Manufacturers (2016-2021)
Table 23. Global Oncolytic Virus Production Market Share by Manufacturers (2016-2021)
Table 24. Global Oncolytic Virus Revenue by Manufacturers (2016-2021)
Table 25. Global Oncolytic Virus Revenue Share by Manufacturers (2016-2021)
Table 26. Global Market Oncolytic Virus Average Price of Key Manufacturers (2016-2021)
Table 27. Manufacturers Oncolytic Virus Production Sites and Area Served
Table 28. Manufacturers Oncolytic Virus Product Type
Table 29. Amgen Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 30. Oncolytics Biotech Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 31. Viralytics Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 32. Table Transgene SA Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 33. Oncolys BioPharma Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 34. Targovax Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 35. PsiOxus Therapeutics Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 36. SillaJen Biotherapeutics Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 37. Sorrento Therapeutics Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 38. Lokon Pharma Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 39. Genelux Corporation Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 40. Vyriad Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 41. TILT Biotherapeutics Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 42. Cold Genesys Oncolytic Virus Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 79. North America Key Players Oncolytic Virus Revenue (2016-2021) (US$ Million)
Table 80. North America Key Players Oncolytic Virus Market Share (2016-2021)
Table 81. North America Oncolytic Virus Market Size by Type (2016-2021) (US$ Million)
Table 82. North America Oncolytic Virus Market Share by Type (2016-2021)
Table 83. North America Oncolytic Virus Market Size by Application (2016-2021) (US$ Million)
Table 84. North America Oncolytic Virus Market Share by Application (2016-2021)
Table 85. East Asia Key Players Oncolytic Virus Revenue (2016-2021) (US$ Million)
Table 86. East Asia Key Players Oncolytic Virus Market Share (2016-2021)
Table 87. East Asia Oncolytic Virus Market Size by Type (2016-2021) (US$ Million)
Table 88. East Asia Oncolytic Virus Market Share by Type (2016-2021)
Table 89. East Asia Oncolytic Virus Market Size by Application (2016-2021) (US$ Million)
Table 90. East Asia Oncolytic Virus Market Share by Application (2016-2021)
Table 91. Market Top Trends
Table 92. Key Drivers: Impact Analysis
Table 93. Key Challenges
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Figure 1. Global Oncolytic Virus Market Size YoY Growth 2022-2027 (US$ Million)
Figure 2. Global Oncolytic Virus Market Share by Regions: 2022 VS 2027
Figure 3. Global Oncolytic Virus Market Size (Value), (US$ Million), 2016 VS 2021 VS 2027
Figure 4. North America Oncolytic Virus Market Size (2016-2027)
Figure 5. East Asia Oncolytic Virus Market Size (2016-2027)
Figure 6. Europe Oncolytic Virus Market Size (2016-2027)
Figure 7. South Asia Oncolytic Virus Market Size (2016-2027)
Figure 8. Southeast Asia Oncolytic Virus Market Size (2016-2027)
Figure 9. Middle East Oncolytic Virus Market Size (2016-2027)
Figure 10. Africa Oncolytic Virus Market Size (2016-2027)
Figure 11. Oceania Oncolytic Virus Market Size (2016-2027)
Figure 12. South America Oncolytic Virus Market Size (2016-2027)
Figure 13. Rest of the World Oncolytic Virus Market Size (2016-2027)
Figure 14. Commodity Prices-Metals Price Indices
Figure 15. Commodity Prices- Precious Metal Price Indices
Figure 16. Commodity Prices- Agricultural Raw Material Price Indices
Figure 17. Commodity Prices- Food and Beverage Price Indices
Figure 18. Commodity Prices- Fertilizer Price Indices
Figure 19. Commodity Prices- Energy Price Indices
Figure 20. G20+: Economic Policy Responses to COVID-19
Figure 21. Imlygic Features
Figure 22. Oncorine Features
Figure 30. Melanoma Case Studies
Figure 39. Amgen Oncolytic Virus Product Specification
Figure 40. Oncolytics Biotech Oncolytic Virus Product Specification
Figure 41. Viralytics Oncolytic Virus Product Specification
Figure 42. Transgene SA Oncolytic Virus Product Specification
Figure 43. Oncolys BioPharma Oncolytic Virus Product Specification
Figure 44. Targovax Oncolytic Virus Product Specification
Figure 45. PsiOxus Therapeutics Oncolytic Virus Product Specification
Figure 46. SillaJen Biotherapeutics Oncolytic Virus Product Specification
Figure 47. Sorrento Therapeutics Oncolytic Virus Product Specification
Figure 48. Lokon Pharma Oncolytic Virus Product Specification
Figure 49. Genelux Corporation Oncolytic Virus Product Specification
Figure 50. Vyriad Oncolytic Virus Product Specification
Figure 51. TILT Biotherapeutics Oncolytic Virus Product Specification
Figure 52. Cold Genesys Oncolytic Virus Product Specification
Figure 89. North America Oncolytic Virus Market Size YoY Growth (2016-2027) (US$ Million)
Figure 90. East Asia Oncolytic Virus Market Size YoY Growth (2016-2027) (US$ Million)
Figure 91. Porter's Five Forces Analysis
Figure 92. Key Executives Interviewed